A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects
Clinical trial NCT04798209 · COMPLETED
Trial details
- NCT number
- NCT04798209
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2022-01-26
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.